These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14658264)

  • 21. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study between prostatic carcinoma G1-G3 and Gleason grading systems.
    Zaharia B; Pleşea IE; Enache SD; Tomescu P; Panuş A; Pop OT; Badea P; Kozokić A
    Rom J Morphol Embryol; 1999-2004; 45():185-97. PubMed ID: 15847394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters.
    Petersen I; Kotb WF; Friedrich KH; Schlüns K; Böcking A; Dietel M
    Lung Cancer; 2009 Sep; 65(3):312-8. PubMed ID: 19168259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia.
    Patton KT; Chen HM; Joseph L; Yang XJ
    Histopathology; 2005 Dec; 47(6):597-601. PubMed ID: 16324197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in the ploidy of prostatic epitheliocyte nuclei during carcinogenesis.
    Avtandilov GG; Gundorova LV
    Bull Exp Biol Med; 2005 Jan; 139(1):91-3. PubMed ID: 16142287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenocarcinomas of the prostatic duct in necropsy material.
    Stamatiou K; Alevizos A; Mariolis A; Fanou D; Alevizou A; Michalodimitrakis E; Sofras F
    Can J Urol; 2007 Apr; 14(2):3502-6. PubMed ID: 17466156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
    Li H; Gerald WL; Benezra R
    Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Precancerous conditions of the prostate--histologic and morphometric investigation].
    Gundorova LV
    Vopr Onkol; 2003; 49(6):738-42. PubMed ID: 14976919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gleason grading of prostatic adenocarcinoma].
    Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):240-3. PubMed ID: 16091182
    [No Abstract]   [Full Text] [Related]  

  • 32. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostate cancer histoseminar: Update of the 2016 WHO classification: Introduction].
    Ferlicot S
    Ann Pathol; 2017 Jun; 37(3):223. PubMed ID: 28522126
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined histologic grading of prostatic carcinoma.
    Böcking A; Kiehn J; Heinzel-Wach M
    Cancer; 1982 Jul; 50(2):288-94. PubMed ID: 7083133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.
    Qiu YQ; Leuschner I; Braun PM
    Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Gleason score prostatic adenocarcinomas are no longer viable entities.
    Berney DM
    Histopathology; 2007 May; 50(6):683-90. PubMed ID: 17493232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of osteopontin contributes to the progression of prostate cancer.
    Khodavirdi AC; Song Z; Yang S; Zhong C; Wang S; Wu H; Pritchard C; Nelson PS; Roy-Burman P
    Cancer Res; 2006 Jan; 66(2):883-8. PubMed ID: 16424021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic significance of tumor cell ploidy in advanced ovarian carcinoma].
    Novik VI; Gevorkian VA; Maksimov SIa
    Vopr Onkol; 2006; 52(1):54-8. PubMed ID: 16715704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma.
    Sauer CG; Roemer A; Grobholz R
    Prostate; 2006 Feb; 66(3):227-34. PubMed ID: 16173029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphometric evaluation of the different classifications used in prostatic carcinoma].
    Vilches J; Aparicio J; López A; Gómez S
    Actas Urol Esp; 1987; 11(1):7-14. PubMed ID: 3577889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.